Literature DB >> 9489528

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination.

G K Wenning1, I Litvan, J Jankovic, R Granata, C A Mangone, A McKee, W Poewe, K Jellinger, K Ray Chaudhuri, L D'Olhaberriague, R K Pearce.   

Abstract

OBJECTIVE: To analyse the natural history and survival of corticobasal degeneration by investigating the clinical features of 14 cases confirmed by postmortem examination.
METHODS: Patients with definite corticobasal degeneration were selected from the research and clinical files of seven tertiary medical centres in Austria, the United Kingdom, and the United States. Clinical features were analysed in detail.
RESULTS: The sample consisted of eight female and six male patients; mean age at symptom onset was 63 (SD 7.7) years, and mean disease duration was 7.9 (SD 2.6) years. The most commonly reported symptom at onset included asymmetric limb clumsiness with or without rigidity (50%) or tremor (21%). At the first neurological visit, on average 3.0 (SD 1.9) years after symptom onset, the most often encountered extrapyramidal features included unilateral limb rigidity (79%) or bradykinesia (71%), postural imbalance (45%), and unilateral limb dystonia (43%). Ideomotor apraxia (64%), and to a lesser extent cortical dementia (36%), were the most common cortical signs present at the first visit. During the course of the disease, virtually all patients developed asymmetric or unilateral akinetic rigid parkinsonism and a gait disorder. No patient had a dramatic response to levodopa therapy. Median survival time after onset of symptoms was 7.9 (SD 0.7) (range, 2.5-12.5) years, and, after the first clinic visit, 4.9 (SD 0.7) (range, 0.8-10) years. Early bilateral bradykinesia, frontal syndrome, or two out of tremor, rigidity, and bradykinesia, predicted a shorter survival.
CONCLUSION: The results confirm that unilateral parkinsonism unresponsive to levodopa and limb ideomotor apraxia are the clinical hallmarks of corticobasal degeneration, and only a minority of patients with corticobasal degeneration present with dementia. The study also suggests that a focal cognitive and extrapyramidal motor syndrome is indicative of corticobasal degeneration. Survival in corticobasal degeneration was shortened by the early presence of (more) widespread parkinsonian features or frontal lobe syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9489528      PMCID: PMC2169933          DOI: 10.1136/jnnp.64.2.184

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography.

Authors:  G V Sawle; D J Brooks; C D Marsden; R S Frackowiak
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

Review 2.  [Atypical Parkinson syndrome].

Authors:  G K Wenning; P P Pramstaller; G Ransmayr; W Poewe
Journal:  Nervenarzt       Date:  1997-02       Impact factor: 1.214

3.  Corticobasal degeneration: neuropathologic and clinical heterogeneity.

Authors:  J A Schneider; R L Watts; M Gearing; R P Brewer; S S Mirra
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Eye movements in parkinsonian syndromes.

Authors:  M Vidailhet; S Rivaud; N Gouider-Khouja; B Pillon; A M Bonnet; B Gaymard; Y Agid; C Pierrot-Deseilligny
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

5.  Corticobasal degeneration. A clinical study of 36 cases.

Authors:  J O Rinne; M S Lee; P D Thompson; C D Marsden
Journal:  Brain       Date:  1994-10       Impact factor: 13.501

Review 6.  Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders.

Authors:  M Savoiardo; F Girotti; L Strada; E Ciceri
Journal:  J Neural Transm Suppl       Date:  1994

7.  The alien hand and related signs.

Authors:  R S Doody; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

Review 8.  PET studies on the early and differential diagnosis of Parkinson's disease.

Authors:  D J Brooks
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

9.  Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

Authors:  J Blin; M J Vidailhet; B Pillon; B Dubois; J R Feve; Y Agid
Journal:  Mov Disord       Date:  1992-10       Impact factor: 10.338

10.  The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus.

Authors:  P D Thompson; B L Day; J C Rothwell; P Brown; T C Britton; C D Marsden
Journal:  Brain       Date:  1994-10       Impact factor: 13.501

View more
  60 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

2.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

3.  Clustering and spatial correlations of the neuronal cytoplasmic inclusions, astrocytic plaques and ballooned neurons in corticobasal degeneration.

Authors:  R A Armstrong; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2009-06-24       Impact factor: 3.575

4.  Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease.

Authors:  Katherine P Rankin; Mary Catherine Mayo; William W Seeley; Suzee Lee; Gil Rabinovici; Maria Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; John Q Trojanowski; Stephen J DeArmond; Bruce L Miller
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 5.  Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.

Authors:  Nikolaus R McFarland; Christopher W Hess
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

6.  Long-term exercise training for an individual with mixed corticobasal degeneration and progressive supranuclear palsy features: 10-year case report follow-up.

Authors:  Teresa M Steffen; Bradley F Boeve; Cheryl M Petersen; Leah Dvorak; Kejal Kantarci
Journal:  Phys Ther       Date:  2013-10-10

7.  Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients.

Authors:  Hatem S Shehata; Nevin M Shalaby; Eman H Esmail; Ebtesam Fahmy
Journal:  Neurol Sci       Date:  2015-04-28       Impact factor: 3.307

Review 8.  Neurodegenerative dementia and parkinsonism.

Authors:  A Gabelle; F Portet; C Berr; J Touchon
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

9.  Diagnosis and treatment of corticobasal degeneration.

Authors:  Melissa J Armstrong
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

10.  A kinematic and electromyographic analysis of turning in people with Parkinson disease.

Authors:  Minna Hong; Joel S Perlmutter; Gammon M Earhart
Journal:  Neurorehabil Neural Repair       Date:  2008-11-03       Impact factor: 3.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.